Riskpilot← Back to searchSign inGet full accessGYNOFORM AB
ABActiveOrg 5565908570Stora Vägen 3Construction of residential and non-residential buildings · NACE 4100Est. 20000 employees
Revenue 2025
SEK 0
EBITDA margin
—
-117% vs 2024
Equity ratio
91.8%
Financial strength
Net profit 2025
SEK -11K
-116% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -16K | -117% |
| Net profit | SEK -11K | -116% |
| Total assets | SEK 146K | -39% |
| Equity | SEK 135K | -31% |
| Employees | 0 | — |
Legal name
GYNOFORM AB
Org number
5565908570
Legal form
Aktiebolag
NACE code
4100 · Construction of residential and non-residential buildings
Founded
10 maj 2000
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av Kempf, Peter Ernst Östberg Kempf, Berit Elisabet
Company purpose
Bolaget skall bedriva arkitektverksamhet, även inrednings- och landskapsarkitektur samt läkarvård inom gynekologi och obstetrik ävensom idka därmed förenlig verksamhet.
Address
Stora Vägen 3
Phone
+4687176570
Email
berit.kempf@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 27 | 0 | 6 | 0 |
| Staff expenses | — | −5 | — | −2 | −0 |
| EBITDA | −247 | −6 | −17 | −8 | −16 |
| Depreciation & amort. | −6 | −6 | −6 | −5 | — |
| EBIT | −253 | −12 | −23 | −13 | −16 |
| Net financials | — | 0 | — | 5 | 5 |
| Profit before tax | 17 | 13 | 227 | 92 | −11 |
| Tax | −7 | −5 | −51 | −21 | — |
| Net profit | 10 | 9 | 176 | 71 | −11 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 109 | 1 575 | 491 | 239 | 146 |
| Equity | 810 | 819 | 305 | 196 | 135 |
| Long-term debt | 0 | — | 0 | — | — |
| Short-term debt | 1 923 | 406 | 87 | 43 | 12 |
| Total debt | 1 923 | 406 | 87 | 43 | 12 |
EBITDA margin
-1642800.0%
This company
15.8%
Market median
-10397568% vs market
20212025
Equity ratio
91.8%
This company
38.2%
Market median
+140% vs market
20212025
Return on equity
-8.4%
This company
18.4%
Market median
-146% vs market
20212025
Net profit margin
-1126400.0%
This company
8.1%
Market median
-13906273% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.09×
This company
0.62×
Market median
+85% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Chairman | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of GYNOFORM AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Peter Ernst Kempf | Board of Directors | 0 companies |
| Anders Camilo Rolo Blomqvist | Deputy Board Member | 0 companies |
| Berit Elisabet Östberg Kempf | Chairman | 0 companies |